Rank | Gene Set | Z-score |
---|---|---|
1 | lymph vessel development (GO:0001945) | 7.17803006 |
2 | endothelium development (GO:0003158) | 6.34023608 |
3 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.34613337 |
4 | behavioral response to nicotine (GO:0035095) | 5.33827375 |
5 | positive regulation of vasculogenesis (GO:2001214) | 5.08450932 |
6 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.87433516 |
7 | lymphangiogenesis (GO:0001946) | 4.75034291 |
8 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.45259129 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.34967362 |
10 | cellular response to exogenous dsRNA (GO:0071360) | 4.23736426 |
11 | microglial cell activation (GO:0001774) | 4.16271029 |
12 | positive regulation of defense response to virus by host (GO:0002230) | 4.08868806 |
13 | I-kappaB phosphorylation (GO:0007252) | 4.02810791 |
14 | regulation of vasculogenesis (GO:2001212) | 4.01064756 |
15 | negative regulation of Rho protein signal transduction (GO:0035024) | 4.00531445 |
16 | L-fucose catabolic process (GO:0042355) | 3.98402530 |
17 | fucose catabolic process (GO:0019317) | 3.98402530 |
18 | L-fucose metabolic process (GO:0042354) | 3.98402530 |
19 | response to pheromone (GO:0019236) | 3.95887378 |
20 | blood vessel maturation (GO:0001955) | 3.91283732 |
21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.86690625 |
22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.86690625 |
23 | modulation by symbiont of host immune response (GO:0052553) | 3.86690625 |
24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.86690625 |
25 | modulation by symbiont of host defense response (GO:0052031) | 3.86690625 |
26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.86690625 |
27 | regulation of germinal center formation (GO:0002634) | 3.80434433 |
28 | tryptophan catabolic process (GO:0006569) | 3.79321367 |
29 | indole-containing compound catabolic process (GO:0042436) | 3.79321367 |
30 | indolalkylamine catabolic process (GO:0046218) | 3.79321367 |
31 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.76319882 |
32 | regulation of endothelial cell differentiation (GO:0045601) | 3.73939533 |
33 | kynurenine metabolic process (GO:0070189) | 3.72987071 |
34 | cytidine deamination (GO:0009972) | 3.66793285 |
35 | cytidine metabolic process (GO:0046087) | 3.66793285 |
36 | cytidine catabolic process (GO:0006216) | 3.66793285 |
37 | B cell receptor signaling pathway (GO:0050853) | 3.59006936 |
38 | surfactant homeostasis (GO:0043129) | 3.57491096 |
39 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.55095025 |
40 | macrophage activation involved in immune response (GO:0002281) | 3.53154650 |
41 | cellular response to ATP (GO:0071318) | 3.49743131 |
42 | cellular extravasation (GO:0045123) | 3.44974625 |
43 | sprouting angiogenesis (GO:0002040) | 3.43198950 |
44 | substrate-dependent cell migration (GO:0006929) | 3.41615260 |
45 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.40472061 |
46 | histamine secretion (GO:0001821) | 3.38717772 |
47 | angiogenesis involved in wound healing (GO:0060055) | 3.38019214 |
48 | B cell proliferation (GO:0042100) | 3.37721962 |
49 | patterning of blood vessels (GO:0001569) | 3.34086584 |
50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33910638 |
51 | endoderm formation (GO:0001706) | 3.33066304 |
52 | germinal center formation (GO:0002467) | 3.30927543 |
53 | macrophage activation (GO:0042116) | 3.30188268 |
54 | negative regulation of mast cell activation (GO:0033004) | 3.29076569 |
55 | indolalkylamine metabolic process (GO:0006586) | 3.27139827 |
56 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.25548343 |
57 | basement membrane organization (GO:0071711) | 3.24352427 |
58 | endothelial cell differentiation (GO:0045446) | 3.21928037 |
59 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.20262202 |
60 | endothelial tube morphogenesis (GO:0061154) | 3.19506063 |
61 | morphogenesis of an endothelium (GO:0003159) | 3.19506063 |
62 | glomerular filtration (GO:0003094) | 3.18188998 |
63 | tryptophan metabolic process (GO:0006568) | 3.17728865 |
64 | protein localization to endosome (GO:0036010) | 3.15501854 |
65 | establishment of endothelial barrier (GO:0061028) | 3.14467903 |
66 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.08639256 |
67 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.07377593 |
68 | endothelial cell morphogenesis (GO:0001886) | 3.06689781 |
69 | negative regulation of B cell proliferation (GO:0030889) | 3.05996401 |
70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05132861 |
71 | NAD biosynthetic process (GO:0009435) | 3.03801978 |
72 | DNA deamination (GO:0045006) | 3.00615112 |
73 | positive regulation of interferon-alpha production (GO:0032727) | 2.93208539 |
74 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.93117897 |
75 | renal filtration (GO:0097205) | 2.92082333 |
76 | positive regulation of macrophage cytokine production (GO:0060907) | 2.89278987 |
77 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.87525397 |
78 | heart trabecula formation (GO:0060347) | 2.87476255 |
79 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.87262366 |
80 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.86899556 |
81 | negative regulation of telomere maintenance (GO:0032205) | 2.86635334 |
82 | regulation of defense response to virus by host (GO:0050691) | 2.86250296 |
83 | Rap protein signal transduction (GO:0032486) | 2.83150971 |
84 | ovulation from ovarian follicle (GO:0001542) | 2.82790843 |
85 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.82434360 |
86 | protein import into peroxisome matrix (GO:0016558) | 2.79283839 |
87 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.78745147 |
88 | response to laminar fluid shear stress (GO:0034616) | 2.76984882 |
89 | cellular response to interferon-beta (GO:0035458) | 2.76967764 |
90 | embryonic heart tube development (GO:0035050) | 2.76214305 |
91 | regulation of interferon-alpha production (GO:0032647) | 2.75840895 |
92 | alanine transport (GO:0032328) | 2.75307229 |
93 | interkinetic nuclear migration (GO:0022027) | 2.74970483 |
94 | transcytosis (GO:0045056) | 2.74493524 |
95 | * positive regulation of Rap GTPase activity (GO:0032854) | 2.72416107 |
96 | mitotic cell cycle arrest (GO:0071850) | 2.72156746 |
97 | cellular ketone body metabolic process (GO:0046950) | 2.72118897 |
98 | cellular biogenic amine catabolic process (GO:0042402) | 2.71685755 |
99 | amine catabolic process (GO:0009310) | 2.71685755 |
100 | positive regulation of antigen processing and presentation (GO:0002579) | 2.71262054 |
101 | indole-containing compound metabolic process (GO:0042430) | 2.71071566 |
102 | cell adhesion mediated by integrin (GO:0033627) | 2.70698804 |
103 | response to fluid shear stress (GO:0034405) | 2.70464668 |
104 | positive regulation of protein kinase C signaling (GO:0090037) | 2.69467545 |
105 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.69079739 |
106 | coronary vasculature morphogenesis (GO:0060977) | 2.68661144 |
107 | regulation of B cell proliferation (GO:0030888) | 2.66465415 |
108 | platelet dense granule organization (GO:0060155) | 2.65951124 |
109 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.65507631 |
110 | positive regulation of heat generation (GO:0031652) | 2.64986386 |
111 | primary amino compound metabolic process (GO:1901160) | 2.64731147 |
112 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.64522450 |
113 | regulation of sarcomere organization (GO:0060297) | 2.63924445 |
114 | germ cell migration (GO:0008354) | 2.63740519 |
115 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.63127869 |
116 | positive regulation of cell junction assembly (GO:1901890) | 2.62956934 |
117 | positive regulation of focal adhesion assembly (GO:0051894) | 2.62956934 |
118 | vasculogenesis (GO:0001570) | 2.62453425 |
119 | glomerular visceral epithelial cell development (GO:0072015) | 2.61099413 |
120 | sulfation (GO:0051923) | 2.61063039 |
121 | T-helper 1 type immune response (GO:0042088) | 2.60252750 |
122 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.59140643 |
123 | sodium-independent organic anion transport (GO:0043252) | 2.57643513 |
124 | mature B cell differentiation (GO:0002335) | 2.57631294 |
125 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.56705874 |
126 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.55558457 |
127 | cortical actin cytoskeleton organization (GO:0030866) | 2.54579786 |
128 | chemical homeostasis within a tissue (GO:0048875) | 2.54429723 |
129 | phagocytosis, engulfment (GO:0006911) | 2.53849699 |
130 | positive regulation of lipid kinase activity (GO:0090218) | 2.52909681 |
131 | blood vessel endothelial cell migration (GO:0043534) | 2.51751739 |
132 | endothelial cell development (GO:0001885) | 2.51622429 |
133 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.50796602 |
134 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.50398517 |
135 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.50398517 |
136 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.50398517 |
137 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.49709783 |
138 | regulation of antigen processing and presentation (GO:0002577) | 2.49411288 |
139 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.48990215 |
140 | positive regulation of B cell differentiation (GO:0045579) | 2.48412447 |
141 | positive regulation of interleukin-12 production (GO:0032735) | 2.47931484 |
142 | synaptic transmission, cholinergic (GO:0007271) | 2.47159200 |
143 | positive regulation of adherens junction organization (GO:1903393) | 2.46739529 |
144 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.46160068 |
145 | detection of light stimulus involved in visual perception (GO:0050908) | 2.46160068 |
146 | positive regulation of chemokine secretion (GO:0090197) | 2.45791307 |
147 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.45630008 |
148 | B cell homeostasis (GO:0001782) | 2.44991925 |
149 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.44892379 |
150 | positive regulation of prostaglandin secretion (GO:0032308) | 2.43995530 |
151 | N-acetylneuraminate metabolic process (GO:0006054) | 2.43915336 |
152 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43498627 |
153 | ketone body metabolic process (GO:1902224) | 2.43200010 |
154 | regulation of platelet activation (GO:0010543) | 2.42989556 |
155 | cAMP catabolic process (GO:0006198) | 2.42841715 |
156 | regulation of establishment of cell polarity (GO:2000114) | 2.42481590 |
157 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.42026898 |
158 | neuronal action potential (GO:0019228) | 2.41630990 |
159 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.40876883 |
160 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.39577128 |
161 | gamma-aminobutyric acid transport (GO:0015812) | 2.38207499 |
162 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.35851305 |
163 | T cell migration (GO:0072678) | 2.34408098 |
164 | positive regulation of protein homooligomerization (GO:0032464) | 2.33840998 |
165 | regulation of T-helper 1 type immune response (GO:0002825) | 2.31039288 |
166 | positive regulation of mast cell activation (GO:0033005) | 2.30580879 |
167 | serotonin metabolic process (GO:0042428) | 2.30211985 |
168 | positive regulation of developmental pigmentation (GO:0048087) | 2.29881095 |
169 | regulation of heat generation (GO:0031650) | 2.28921113 |
170 | renal tubule morphogenesis (GO:0061333) | 2.28227332 |
171 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.27462751 |
172 | interferon-gamma production (GO:0032609) | 2.27381255 |
173 | regulation of synapse structural plasticity (GO:0051823) | 2.26977064 |
174 | positive regulation of fatty acid transport (GO:2000193) | 2.26967478 |
175 | response to protozoan (GO:0001562) | 2.26867322 |
176 | purinergic receptor signaling pathway (GO:0035587) | 2.26602259 |
177 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.26420920 |
178 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.26147901 |
179 | nephron tubule morphogenesis (GO:0072078) | 2.25860443 |
180 | nephron epithelium morphogenesis (GO:0072088) | 2.25860443 |
181 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.25158317 |
182 | negative regulation of interleukin-1 production (GO:0032692) | 2.22555032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.47599841 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.82046408 |
3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.45649378 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.33173194 |
5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.25541942 |
6 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.24358219 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12708068 |
8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.99627293 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.95241446 |
10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.82098771 |
11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69828534 |
12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59144960 |
13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51384202 |
14 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.39178583 |
15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35294135 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.26527006 |
17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12860086 |
18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.10476582 |
19 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.09660796 |
20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.02216007 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01138113 |
22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99787593 |
23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.99665298 |
24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.95194156 |
25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.92729893 |
26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.91678709 |
27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87566884 |
28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.84803758 |
29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82344185 |
30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.81137939 |
31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73018037 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.72657886 |
33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70405060 |
34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63561705 |
35 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.60106820 |
36 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.59749097 |
37 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.58574735 |
38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.58241354 |
39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57950241 |
40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55390684 |
41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52608772 |
42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.51990469 |
43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51270928 |
44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.49920935 |
45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48527339 |
46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.48019585 |
47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.47421376 |
48 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.45654980 |
49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.45197012 |
50 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.45197012 |
51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44737609 |
52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43327276 |
53 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.43063820 |
54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41006341 |
55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39130938 |
56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38714841 |
57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38549639 |
58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38022114 |
59 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37547727 |
60 | TP53_16413492_ChIP-PET_HCT116_Human | 1.37415536 |
61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36039767 |
62 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35604802 |
63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35303904 |
64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34861806 |
65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32978298 |
66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32466172 |
67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32335298 |
68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32090528 |
69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28950353 |
70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27281406 |
71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26078346 |
72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25714786 |
73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25073130 |
74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24937502 |
75 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24106008 |
76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24106008 |
77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23255130 |
78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21174024 |
79 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21171302 |
80 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20975684 |
81 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20326863 |
82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19845996 |
83 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19465338 |
84 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.18752417 |
85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17225947 |
86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17225947 |
87 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.15531577 |
88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15300997 |
89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14892570 |
90 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14052447 |
91 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.13249266 |
92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12401521 |
93 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12120652 |
94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11913246 |
95 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11763460 |
96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11460015 |
97 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.11225861 |
98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11099626 |
99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11003389 |
100 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09868001 |
101 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08883552 |
102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.08595259 |
103 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07612200 |
104 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07612200 |
105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06682204 |
106 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06682204 |
107 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06561323 |
108 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05201562 |
109 | MAF_26560356_Chip-Seq_TH1_Human | 1.04486028 |
110 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04328553 |
111 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04210494 |
112 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03964966 |
113 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03915471 |
114 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03692083 |
115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03622598 |
116 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03378117 |
117 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01536348 |
118 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01187910 |
119 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00844778 |
120 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.00807847 |
121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00064663 |
122 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99637742 |
123 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99556301 |
124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99138592 |
125 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99109403 |
126 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98829937 |
127 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98423447 |
128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97971829 |
129 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97459444 |
130 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97207251 |
131 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97159641 |
132 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97052393 |
133 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95334943 |
134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95287660 |
135 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94819137 |
136 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94589887 |
137 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94162285 |
138 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93877050 |
139 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93828632 |
140 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93722280 |
141 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93643780 |
142 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92888835 |
143 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92877054 |
144 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.92854318 |
145 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92545897 |
146 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92539906 |
147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92313062 |
148 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.91924194 |
149 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.91186687 |
150 | ERA_21632823_ChIP-Seq_H3396_Human | 0.91087874 |
151 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91007606 |
152 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90928301 |
153 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90785436 |
154 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90590432 |
155 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90265801 |
156 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89959162 |
157 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.89804255 |
158 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89356168 |
159 | MYB_26560356_Chip-Seq_TH1_Human | 0.88978894 |
160 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.88941194 |
161 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88576421 |
162 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88576421 |
163 | * MYB_26560356_Chip-Seq_TH2_Human | 0.88373540 |
164 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88336211 |
165 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88213521 |
166 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88001940 |
167 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87816619 |
168 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87511780 |
169 | FUS_26573619_Chip-Seq_HEK293_Human | 0.87447007 |
170 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86919868 |
171 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.86419800 |
172 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85930666 |
173 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84717186 |
174 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83331620 |
175 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83164699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010368_abnormal_lymphatic_system | 5.85022130 |
2 | MP0001879_abnormal_lymphatic_vessel | 5.78805803 |
3 | MP0005167_abnormal_blood-brain_barrier | 3.86499583 |
4 | MP0004272_abnormal_basement_membrane | 3.41794815 |
5 | MP0003828_pulmonary_edema | 3.35346379 |
6 | MP0006054_spinal_hemorrhage | 3.34022156 |
7 | MP0003646_muscle_fatigue | 3.05834509 |
8 | MP0003195_calcinosis | 2.76312521 |
9 | MP0005171_absent_coat_pigmentation | 2.61391902 |
10 | MP0003303_peritoneal_inflammation | 2.46712704 |
11 | MP0003724_increased_susceptibility_to | 2.44000344 |
12 | MP0001835_abnormal_antigen_presentation | 2.43721553 |
13 | MP0000767_abnormal_smooth_muscle | 2.40834141 |
14 | MP0005623_abnormal_meninges_morphology | 2.19553893 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.15238479 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 2.15041138 |
17 | MP0000569_abnormal_digit_pigmentation | 1.97099940 |
18 | MP0005409_darkened_coat_color | 1.94775585 |
19 | MP0003300_gastrointestinal_ulcer | 1.90453721 |
20 | MP0009785_altered_susceptibility_to | 1.88706387 |
21 | MP0001986_abnormal_taste_sensitivity | 1.88246896 |
22 | MP0004084_abnormal_cardiac_muscle | 1.86882099 |
23 | * MP0001800_abnormal_humoral_immune | 1.84836395 |
24 | MP0003136_yellow_coat_color | 1.84282974 |
25 | MP0003279_aneurysm | 1.78586193 |
26 | MP0000465_gastrointestinal_hemorrhage | 1.78432736 |
27 | MP0001790_abnormal_immune_system | 1.76075989 |
28 | MP0005387_immune_system_phenotype | 1.76075989 |
29 | MP0005671_abnormal_response_to | 1.74973628 |
30 | MP0000249_abnormal_blood_vessel | 1.74516094 |
31 | MP0004510_myositis | 1.73221960 |
32 | MP0009764_decreased_sensitivity_to | 1.71994633 |
33 | * MP0002452_abnormal_antigen_presenting | 1.70139328 |
34 | MP0004043_abnormal_pH_regulation | 1.69161958 |
35 | MP0004484_altered_response_of | 1.67124726 |
36 | MP0009046_muscle_twitch | 1.65512807 |
37 | MP0003690_abnormal_glial_cell | 1.64558214 |
38 | MP0005025_abnormal_response_to | 1.58722426 |
39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.53286429 |
40 | MP0003091_abnormal_cell_migration | 1.53067702 |
41 | MP0009840_abnormal_foam_cell | 1.52481230 |
42 | MP0010234_abnormal_vibrissa_follicle | 1.51925712 |
43 | MP0006138_congestive_heart_failure | 1.51850343 |
44 | MP0005174_abnormal_tail_pigmentation | 1.49436862 |
45 | MP0004130_abnormal_muscle_cell | 1.46584996 |
46 | MP0003566_abnormal_cell_adhesion | 1.46132754 |
47 | MP0002419_abnormal_innate_immunity | 1.44613137 |
48 | MP0005165_increased_susceptibility_to | 1.42114013 |
49 | MP0004883_abnormal_blood_vessel | 1.40677072 |
50 | MP0003045_fibrosis | 1.40431131 |
51 | MP0005645_abnormal_hypothalamus_physiol | 1.39835131 |
52 | MP0004036_abnormal_muscle_relaxation | 1.39411668 |
53 | MP0005310_abnormal_salivary_gland | 1.38353854 |
54 | MP0005551_abnormal_eye_electrophysiolog | 1.38076290 |
55 | MP0001851_eye_inflammation | 1.37083018 |
56 | MP0000013_abnormal_adipose_tissue | 1.36740165 |
57 | MP0000920_abnormal_myelination | 1.35491440 |
58 | MP0001915_intracranial_hemorrhage | 1.33945810 |
59 | MP0006082_CNS_inflammation | 1.33285893 |
60 | MP0009745_abnormal_behavioral_response | 1.32279799 |
61 | MP0004142_abnormal_muscle_tone | 1.31095459 |
62 | MP0008872_abnormal_physiological_respon | 1.31043476 |
63 | MP0003252_abnormal_bile_duct | 1.30737771 |
64 | MP0005058_abnormal_lysosome_morphology | 1.30444078 |
65 | MP0010630_abnormal_cardiac_muscle | 1.28980784 |
66 | MP0005000_abnormal_immune_tolerance | 1.27946389 |
67 | * MP0002723_abnormal_immune_serum | 1.27518893 |
68 | MP0002925_abnormal_cardiovascular_devel | 1.26166387 |
69 | MP0002128_abnormal_blood_circulation | 1.25854877 |
70 | MP0002332_abnormal_exercise_endurance | 1.24302147 |
71 | MP0008877_abnormal_DNA_methylation | 1.22798789 |
72 | MP0005464_abnormal_platelet_physiology | 1.22600626 |
73 | MP0003950_abnormal_plasma_membrane | 1.21952827 |
74 | MP0002405_respiratory_system_inflammati | 1.20901688 |
75 | * MP0002420_abnormal_adaptive_immunity | 1.20607002 |
76 | * MP0001819_abnormal_immune_cell | 1.19580766 |
77 | MP0001968_abnormal_touch/_nociception | 1.17656829 |
78 | MP0001873_stomach_inflammation | 1.16506245 |
79 | MP0002102_abnormal_ear_morphology | 1.15464664 |
80 | MP0001614_abnormal_blood_vessel | 1.15422638 |
81 | MP0004885_abnormal_endolymph | 1.14554383 |
82 | MP0002735_abnormal_chemical_nociception | 1.12889378 |
83 | MP0000372_irregular_coat_pigmentation | 1.11019331 |
84 | MP0005595_abnormal_vascular_smooth | 1.10974837 |
85 | MP0000749_muscle_degeneration | 1.09910018 |
86 | MP0001501_abnormal_sleep_pattern | 1.09820240 |
87 | MP0001845_abnormal_inflammatory_respons | 1.09439455 |
88 | MP0004742_abnormal_vestibular_system | 1.09249390 |
89 | MP0005385_cardiovascular_system_phenoty | 1.08424663 |
90 | MP0001544_abnormal_cardiovascular_syste | 1.08424663 |
91 | MP0002064_seizures | 1.07508530 |
92 | MP0002653_abnormal_ependyma_morphology | 1.05947994 |
93 | MP0010678_abnormal_skin_adnexa | 1.05607928 |
94 | MP0000003_abnormal_adipose_tissue | 1.05277288 |
95 | MP0001853_heart_inflammation | 1.05176242 |
96 | MP0002972_abnormal_cardiac_muscle | 1.02727998 |
97 | MP0002148_abnormal_hypersensitivity_rea | 1.00747389 |
98 | MP0002138_abnormal_hepatobiliary_system | 1.00700889 |
99 | MP0005164_abnormal_response_to | 1.00567425 |
100 | MP0003172_abnormal_lysosome_physiology | 1.00386126 |
101 | MP0000733_abnormal_muscle_development | 1.00196358 |
102 | MP0004147_increased_porphyrin_level | 0.99607864 |
103 | MP0001663_abnormal_digestive_system | 0.98357977 |
104 | MP0005330_cardiomyopathy | 0.96352265 |
105 | MP0000343_altered_response_to | 0.96101678 |
106 | MP0002139_abnormal_hepatobiliary_system | 0.95331158 |
107 | MP0002876_abnormal_thyroid_physiology | 0.94160682 |
108 | MP0005084_abnormal_gallbladder_morpholo | 0.93861418 |
109 | MP0002928_abnormal_bile_duct | 0.93154736 |
110 | MP0001958_emphysema | 0.92897235 |
111 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92743092 |
112 | MP0002272_abnormal_nervous_system | 0.90761949 |
113 | MP0002638_abnormal_pupillary_reflex | 0.90708824 |
114 | MP0000230_abnormal_systemic_arterial | 0.90512135 |
115 | MP0002933_joint_inflammation | 0.89767497 |
116 | MP0004145_abnormal_muscle_electrophysio | 0.89342703 |
117 | MP0001784_abnormal_fluid_regulation | 0.88982603 |
118 | MP0004215_abnormal_myocardial_fiber | 0.88800854 |
119 | MP0005670_abnormal_white_adipose | 0.86880818 |
120 | MP0005408_hypopigmentation | 0.86139036 |
121 | MP0008775_abnormal_heart_ventricle | 0.85711477 |
122 | MP0002067_abnormal_sensory_capabilities | 0.85629761 |
123 | MP0000015_abnormal_ear_pigmentation | 0.84209881 |
124 | MP0005085_abnormal_gallbladder_physiolo | 0.83305973 |
125 | MP0002396_abnormal_hematopoietic_system | 0.83043237 |
126 | * MP0000716_abnormal_immune_system | 0.82825309 |
127 | MP0002166_altered_tumor_susceptibility | 0.82397144 |
128 | * MP0002429_abnormal_blood_cell | 0.82246620 |
129 | MP0000689_abnormal_spleen_morphology | 0.82220533 |
130 | MP0009278_abnormal_bone_marrow | 0.82127577 |
131 | MP0002127_abnormal_cardiovascular_syste | 0.82034659 |
132 | MP0008469_abnormal_protein_level | 0.81904575 |
133 | MP0000266_abnormal_heart_morphology | 0.81718896 |
134 | MP0001919_abnormal_reproductive_system | 0.81670952 |
135 | MP0005620_abnormal_muscle_contractility | 0.81270703 |
136 | MP0002295_abnormal_pulmonary_circulatio | 0.80157809 |
137 | MP0003763_abnormal_thymus_physiology | 0.79934587 |
138 | MP0003436_decreased_susceptibility_to | 0.79893442 |
139 | MP0001533_abnormal_skeleton_physiology | 0.79644586 |
140 | MP0002398_abnormal_bone_marrow | 0.78638544 |
141 | MP0010386_abnormal_urinary_bladder | 0.78496444 |
142 | MP0003943_abnormal_hepatobiliary_system | 0.77197411 |
143 | MP0003633_abnormal_nervous_system | 0.77146052 |
144 | MP0002277_abnormal_respiratory_mucosa | 0.76765744 |
145 | MP0001970_abnormal_pain_threshold | 0.76692444 |
146 | MP0010155_abnormal_intestine_physiology | 0.75865264 |
147 | MP0002733_abnormal_thermal_nociception | 0.75243185 |
148 | MP0002693_abnormal_pancreas_physiology | 0.74737866 |
149 | MP0004087_abnormal_muscle_fiber | 0.73518676 |
150 | MP0000685_abnormal_immune_system | 0.73385678 |
151 | MP0002133_abnormal_respiratory_system | 0.73220580 |
152 | MP0005388_respiratory_system_phenotype | 0.73220580 |
153 | MP0004924_abnormal_behavior | 0.72808346 |
154 | MP0005386_behavior/neurological_phenoty | 0.72808346 |
155 | MP0005253_abnormal_eye_physiology | 0.72364661 |
156 | MP0005266_abnormal_metabolism | 0.72220982 |
157 | MP0005448_abnormal_energy_balance | 0.71551276 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hematochezia (HP:0002573) | 5.47566664 |
2 | Colitis (HP:0002583) | 5.06720563 |
3 | Cerebral aneurysm (HP:0004944) | 4.61620994 |
4 | Spontaneous hematomas (HP:0007420) | 4.41924902 |
5 | Vascular tortuosity (HP:0004948) | 4.41532657 |
6 | Arterial tortuosity (HP:0005116) | 4.34697562 |
7 | Agammaglobulinemia (HP:0004432) | 4.15010659 |
8 | Aortic aneurysm (HP:0004942) | 3.96577802 |
9 | Congenital stationary night blindness (HP:0007642) | 3.94350985 |
10 | Systemic lupus erythematosus (HP:0002725) | 3.82343685 |
11 | Pancreatic cysts (HP:0001737) | 3.79940878 |
12 | Polycythemia (HP:0001901) | 3.77650248 |
13 | Gastrointestinal stroma tumor (HP:0100723) | 3.68560648 |
14 | Inflammation of the large intestine (HP:0002037) | 3.50881910 |
15 | Abnormality of midbrain morphology (HP:0002418) | 3.49475815 |
16 | Molar tooth sign on MRI (HP:0002419) | 3.49475815 |
17 | Glomerulonephritis (HP:0000099) | 3.40601467 |
18 | Tubular atrophy (HP:0000092) | 3.40378490 |
19 | Congenital, generalized hypertrichosis (HP:0004540) | 3.36441263 |
20 | Abnormal drinking behavior (HP:0030082) | 3.23907873 |
21 | Polydipsia (HP:0001959) | 3.23907873 |
22 | Axonal loss (HP:0003447) | 3.22705098 |
23 | Cellulitis (HP:0100658) | 3.19734844 |
24 | Gastrointestinal inflammation (HP:0004386) | 3.10844255 |
25 | Vacuolated lymphocytes (HP:0001922) | 3.06308850 |
26 | Inability to walk (HP:0002540) | 3.05199048 |
27 | Nonimmune hydrops fetalis (HP:0001790) | 3.03454196 |
28 | Abnormality of alanine metabolism (HP:0010916) | 3.02788521 |
29 | Hyperalaninemia (HP:0003348) | 3.02788521 |
30 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.02788521 |
31 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.98641882 |
32 | Hyperventilation (HP:0002883) | 2.97868036 |
33 | Attenuation of retinal blood vessels (HP:0007843) | 2.97324744 |
34 | Esophageal varix (HP:0002040) | 2.96646748 |
35 | Pancreatic fibrosis (HP:0100732) | 2.89045030 |
36 | Type II lissencephaly (HP:0007260) | 2.88280406 |
37 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.87185267 |
38 | Nephronophthisis (HP:0000090) | 2.83074164 |
39 | Abnormality of the renal cortex (HP:0011035) | 2.78960123 |
40 | Facial diplegia (HP:0001349) | 2.78914234 |
41 | Disproportionate tall stature (HP:0001519) | 2.78234992 |
42 | Myocardial infarction (HP:0001658) | 2.76694408 |
43 | Recurrent abscess formation (HP:0002722) | 2.76183316 |
44 | Decreased circulating renin level (HP:0003351) | 2.71801384 |
45 | True hermaphroditism (HP:0010459) | 2.70129208 |
46 | Aortic dissection (HP:0002647) | 2.66797140 |
47 | Conjunctival telangiectasia (HP:0000524) | 2.65918764 |
48 | Birth length less than 3rd percentile (HP:0003561) | 2.63489334 |
49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61965347 |
50 | Abnormality of the renal medulla (HP:0100957) | 2.59959874 |
51 | Emphysema (HP:0002097) | 2.59274783 |
52 | Increased cerebral lipofuscin (HP:0011813) | 2.59194153 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58860376 |
54 | Cerebral hemorrhage (HP:0001342) | 2.58175199 |
55 | Hemiparesis (HP:0001269) | 2.56029128 |
56 | Difficulty running (HP:0009046) | 2.55095602 |
57 | Clumsiness (HP:0002312) | 2.54217681 |
58 | Onion bulb formation (HP:0003383) | 2.53522807 |
59 | Absent hand (HP:0004050) | 2.50307770 |
60 | Hypoplasia of the iris (HP:0007676) | 2.48680008 |
61 | Protruding tongue (HP:0010808) | 2.47844034 |
62 | Diplopia (HP:0000651) | 2.45559735 |
63 | Abnormality of binocular vision (HP:0011514) | 2.45559735 |
64 | Muscle fiber splitting (HP:0003555) | 2.45410154 |
65 | Global brain atrophy (HP:0002283) | 2.44886948 |
66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41786730 |
67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41786730 |
68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41786730 |
69 | Large for gestational age (HP:0001520) | 2.39551560 |
70 | Autoimmune thrombocytopenia (HP:0001973) | 2.38502345 |
71 | Stomatitis (HP:0010280) | 2.38490131 |
72 | Polyuria (HP:0000103) | 2.37318363 |
73 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.36133311 |
74 | Complement deficiency (HP:0004431) | 2.35755255 |
75 | Hyporeflexia of lower limbs (HP:0002600) | 2.34840486 |
76 | Thick nail (HP:0001805) | 2.33906814 |
77 | Recurrent pneumonia (HP:0006532) | 2.33800436 |
78 | Progressive inability to walk (HP:0002505) | 2.33046411 |
79 | Bile duct proliferation (HP:0001408) | 2.32995588 |
80 | Abnormal biliary tract physiology (HP:0012439) | 2.32995588 |
81 | Abolished electroretinogram (ERG) (HP:0000550) | 2.31628800 |
82 | Recurrent viral infections (HP:0004429) | 2.30225391 |
83 | Chronic hepatic failure (HP:0100626) | 2.29407435 |
84 | Genetic anticipation (HP:0003743) | 2.28757467 |
85 | Viral hepatitis (HP:0006562) | 2.28672733 |
86 | Recurrent bacterial skin infections (HP:0005406) | 2.28326623 |
87 | Chronic diarrhea (HP:0002028) | 2.27467207 |
88 | Urethral obstruction (HP:0000796) | 2.27212207 |
89 | Hemiplegia (HP:0002301) | 2.27190333 |
90 | Osteomyelitis (HP:0002754) | 2.26992928 |
91 | Mucosal telangiectasiae (HP:0100579) | 2.26024082 |
92 | Stomach cancer (HP:0012126) | 2.23755887 |
93 | Congenital hepatic fibrosis (HP:0002612) | 2.22623084 |
94 | Optic neuritis (HP:0100653) | 2.21829026 |
95 | Retrobulbar optic neuritis (HP:0100654) | 2.21829026 |
96 | Adactyly (HP:0009776) | 2.21382005 |
97 | Subacute progressive viral hepatitis (HP:0006572) | 2.21237915 |
98 | IgG deficiency (HP:0004315) | 2.21060340 |
99 | Bicuspid aortic valve (HP:0001647) | 2.20755039 |
100 | Striae distensae (HP:0001065) | 2.19657698 |
101 | Recurrent sinusitis (HP:0011108) | 2.18166062 |
102 | Fair hair (HP:0002286) | 2.17553265 |
103 | Dysostosis multiplex (HP:0000943) | 2.17220416 |
104 | Restrictive lung disease (HP:0002091) | 2.16901233 |
105 | Peripheral demyelination (HP:0011096) | 2.14705166 |
106 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08637939 |
107 | Gaze-evoked nystagmus (HP:0000640) | 2.08473460 |
108 | Cystic liver disease (HP:0006706) | 2.08420668 |
109 | EMG: myopathic abnormalities (HP:0003458) | 2.07422268 |
110 | Portal hypertension (HP:0001409) | 2.05590048 |
111 | Nephritis (HP:0000123) | 2.05585690 |
112 | Papilloma (HP:0012740) | 2.05038805 |
113 | Verrucae (HP:0200043) | 2.05038805 |
114 | Abnormality of the right ventricle (HP:0001707) | 2.04289844 |
115 | Lymphangioma (HP:0100764) | 2.03246140 |
116 | Thyroiditis (HP:0100646) | 2.02983519 |
117 | Recurrent skin infections (HP:0001581) | 2.02479611 |
118 | Severe muscular hypotonia (HP:0006829) | 2.02270106 |
119 | Retinal atrophy (HP:0001105) | 2.02239155 |
120 | Progressive cerebellar ataxia (HP:0002073) | 2.00086265 |
121 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99838634 |
122 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99838634 |
123 | Lymphopenia (HP:0001888) | 1.99087591 |
124 | Furrowed tongue (HP:0000221) | 1.97783360 |
125 | Exercise-induced muscle cramps (HP:0003710) | 1.96811753 |
126 | IgA deficiency (HP:0002720) | 1.95819484 |
127 | Hemoptysis (HP:0002105) | 1.94542384 |
128 | Broad-based gait (HP:0002136) | 1.93930047 |
129 | Aplasia cutis congenita (HP:0001057) | 1.93758286 |
130 | Decreased central vision (HP:0007663) | 1.91981229 |
131 | Exotropia (HP:0000577) | 1.91448443 |
132 | Skull defect (HP:0001362) | 1.91349486 |
133 | Porencephaly (HP:0002132) | 1.91048420 |
134 | Pendular nystagmus (HP:0012043) | 1.90701499 |
135 | Metabolic alkalosis (HP:0200114) | 1.90627992 |
136 | Aneurysm (HP:0002617) | 1.88846501 |
137 | Abnormal urine output (HP:0012590) | 1.88335791 |
138 | Pulmonary infiltrates (HP:0002113) | 1.88024952 |
139 | Cerebellar dysplasia (HP:0007033) | 1.87162059 |
140 | Congenital sensorineural hearing impairment (HP:0008527) | 1.86800780 |
141 | Recurrent fungal infections (HP:0002841) | 1.86612188 |
142 | Patellar aplasia (HP:0006443) | 1.86408902 |
143 | Concave nail (HP:0001598) | 1.85990670 |
144 | Mitral valve prolapse (HP:0001634) | 1.85364591 |
145 | Prostate neoplasm (HP:0100787) | 1.85298490 |
146 | Eosinophilia (HP:0001880) | 1.83113146 |
147 | Pulmonary artery stenosis (HP:0004415) | 1.82097175 |
148 | Sepsis (HP:0100806) | 1.81700134 |
149 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81687649 |
150 | Abnormality of the prostate (HP:0008775) | 1.80903332 |
151 | Generalized hypopigmentation of hair (HP:0011358) | 1.80202865 |
152 | Mitral stenosis (HP:0001718) | 1.79807460 |
153 | Abnormality of the hepatic vasculature (HP:0006707) | 1.79774244 |
154 | Abnormality of the pons (HP:0007361) | 1.79095795 |
155 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.78877140 |
156 | Pulmonary embolism (HP:0002204) | 1.78720672 |
157 | Mesangial abnormality (HP:0001966) | 1.78468188 |
158 | Recurrent bronchitis (HP:0002837) | 1.78082301 |
159 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.77925275 |
160 | Vasculitis (HP:0002633) | 1.77898151 |
161 | Abnormality of B cell number (HP:0010975) | 1.77416450 |
162 | B lymphocytopenia (HP:0010976) | 1.77416450 |
163 | Abnormal pancreas size (HP:0012094) | 1.77160679 |
164 | Abnormality of T cell physiology (HP:0011840) | 1.77074337 |
165 | Encephalitis (HP:0002383) | 1.76975634 |
166 | Venous insufficiency (HP:0005293) | 1.76214617 |
167 | Spondylolisthesis (HP:0003302) | 1.76087137 |
168 | Short chin (HP:0000331) | 1.75849928 |
169 | Medial flaring of the eyebrow (HP:0010747) | 1.74298306 |
170 | Tubulointerstitial fibrosis (HP:0005576) | 1.74186557 |
171 | Febrile seizures (HP:0002373) | 1.74050099 |
172 | Hemorrhage of the eye (HP:0011885) | 1.73382625 |
173 | Intestinal atresia (HP:0011100) | 1.72924956 |
174 | Confusion (HP:0001289) | 1.72803028 |
175 | Dyskinesia (HP:0100660) | 1.72487507 |
176 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.72476159 |
177 | IgM deficiency (HP:0002850) | 1.71873260 |
178 | Eczematoid dermatitis (HP:0000976) | 1.71817970 |
179 | Premature skin wrinkling (HP:0100678) | 1.71489944 |
180 | Lissencephaly (HP:0001339) | 1.71379080 |
181 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.70665451 |
182 | Meningitis (HP:0001287) | 1.70306637 |
183 | Abnormality of complement system (HP:0005339) | 1.69779662 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 6.91586680 |
2 | TGFBR2 | 6.05952430 |
3 | KDR | 5.40439113 |
4 | ACVR1B | 3.50012780 |
5 | FRK | 3.40573473 |
6 | ADRBK2 | 3.30064211 |
7 | TLK1 | 2.65139426 |
8 | MAP4K1 | 2.29380759 |
9 | MAP3K14 | 2.23616014 |
10 | DAPK2 | 1.93425146 |
11 | WNK4 | 1.89697458 |
12 | CSF1R | 1.84632773 |
13 | TAOK3 | 1.79586298 |
14 | MAPK12 | 1.78749668 |
15 | GRK7 | 1.78738109 |
16 | CAMK1G | 1.74090441 |
17 | CAMK1D | 1.65414317 |
18 | TGFBR1 | 1.63749127 |
19 | CAMKK2 | 1.62414305 |
20 | MAPK15 | 1.62103281 |
21 | ITK | 1.55972888 |
22 | DMPK | 1.55202006 |
23 | PDK2 | 1.54666685 |
24 | EPHB1 | 1.52038911 |
25 | TXK | 1.46120112 |
26 | GRK1 | 1.45499467 |
27 | TSSK6 | 1.44316768 |
28 | ZAK | 1.43554355 |
29 | STK10 | 1.42124860 |
30 | PINK1 | 1.41731510 |
31 | MAPK7 | 1.36643791 |
32 | PTK2B | 1.33642977 |
33 | TYK2 | 1.33435723 |
34 | TEC | 1.33037515 |
35 | FES | 1.27907859 |
36 | BLK | 1.26326542 |
37 | OXSR1 | 1.24984143 |
38 | MARK3 | 1.23686842 |
39 | PNCK | 1.21174684 |
40 | PKN1 | 1.19401295 |
41 | CSK | 1.17993323 |
42 | ERN1 | 1.17981416 |
43 | CLK1 | 1.17085932 |
44 | KIT | 1.16162843 |
45 | INSRR | 1.14220895 |
46 | TBK1 | 1.11324005 |
47 | PRKD1 | 1.10017687 |
48 | BMPR1B | 1.08164004 |
49 | IRAK4 | 1.05040948 |
50 | ADRBK1 | 1.03541630 |
51 | PTK6 | 1.02625086 |
52 | RIPK1 | 1.02342184 |
53 | PRKCH | 1.00992362 |
54 | IRAK1 | 1.00011022 |
55 | CHUK | 0.99073825 |
56 | HCK | 0.98242382 |
57 | JAK3 | 0.97667319 |
58 | MAP2K3 | 0.95973406 |
59 | MAPK13 | 0.95885184 |
60 | JAK1 | 0.92577823 |
61 | STK39 | 0.91344055 |
62 | FGFR2 | 0.91127161 |
63 | CSNK1A1L | 0.90117663 |
64 | WNK3 | 0.89147678 |
65 | SIK2 | 0.88774041 |
66 | MAP4K2 | 0.87380033 |
67 | LYN | 0.86678838 |
68 | IRAK3 | 0.85861737 |
69 | MAPKAPK3 | 0.85694969 |
70 | BRD4 | 0.85279658 |
71 | EPHB2 | 0.84833191 |
72 | NEK9 | 0.84331279 |
73 | MAP2K6 | 0.83831656 |
74 | RIPK4 | 0.82776546 |
75 | WNK1 | 0.82666735 |
76 | CAMKK1 | 0.82331598 |
77 | TRPM7 | 0.82207703 |
78 | TTN | 0.80921741 |
79 | TNIK | 0.75509170 |
80 | SYK | 0.74908101 |
81 | PAK4 | 0.74181915 |
82 | LRRK2 | 0.71614451 |
83 | RPS6KA5 | 0.70953175 |
84 | MKNK2 | 0.70567409 |
85 | FER | 0.68462491 |
86 | BMPR2 | 0.67111521 |
87 | PIK3CG | 0.66926048 |
88 | FGFR3 | 0.64593958 |
89 | PDPK1 | 0.64591877 |
90 | GSK3A | 0.64346736 |
91 | NUAK1 | 0.64237952 |
92 | IGF1R | 0.63556681 |
93 | LCK | 0.59724415 |
94 | PDK1 | 0.59520862 |
95 | PRKAA2 | 0.58339947 |
96 | RPS6KA6 | 0.58058047 |
97 | INSR | 0.57739075 |
98 | PKN2 | 0.56706931 |
99 | EGFR | 0.56586715 |
100 | TYRO3 | 0.54736836 |
101 | PIM1 | 0.54716415 |
102 | BTK | 0.54113832 |
103 | PRKCG | 0.52712088 |
104 | STK11 | 0.51681373 |
105 | CSNK1G1 | 0.49047491 |
106 | PAK2 | 0.48261781 |
107 | PDGFRB | 0.48140747 |
108 | MAP3K13 | 0.46610636 |
109 | OBSCN | 0.46336967 |
110 | * PRKCQ | 0.46261700 |
111 | NEK6 | 0.45600438 |
112 | MAP2K1 | 0.45328364 |
113 | ZAP70 | 0.44400280 |
114 | ABL1 | 0.44330101 |
115 | MAPKAPK5 | 0.42059205 |
116 | IKBKB | 0.41814710 |
117 | MAPKAPK2 | 0.41244288 |
118 | PIK3CA | 0.39360816 |
119 | PRKCE | 0.38667502 |
120 | CCNB1 | 0.38137034 |
121 | PAK3 | 0.37964649 |
122 | STK3 | 0.36904711 |
123 | VRK1 | 0.36283574 |
124 | CDC42BPA | 0.35874887 |
125 | MAPK11 | 0.35840452 |
126 | SRC | 0.35182420 |
127 | CSNK1G3 | 0.34305711 |
128 | CAMK4 | 0.34180337 |
129 | FYN | 0.33806611 |
130 | MARK2 | 0.33631235 |
131 | MAP3K4 | 0.33510290 |
132 | FGR | 0.33371434 |
133 | PRKG2 | 0.33307413 |
134 | SIK3 | 0.33234797 |
135 | MATK | 0.33174242 |
136 | MAPK4 | 0.33076746 |
137 | IKBKE | 0.31476015 |
138 | MET | 0.31396361 |
139 | NEK2 | 0.31307889 |
140 | SGK223 | 0.31174391 |
141 | SGK494 | 0.31174391 |
142 | PHKG2 | 0.30677800 |
143 | PHKG1 | 0.30677800 |
144 | CAMK2A | 0.30534223 |
145 | MAP3K9 | 0.29975637 |
146 | CAMK1 | 0.29272437 |
147 | SGK2 | 0.28542417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Asthma_Homo sapiens_hsa05310 | 3.52098428 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.21052026 |
3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.89813044 |
4 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.89067385 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.87690916 |
6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.30578555 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25223966 |
8 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.23504741 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22869127 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13688674 |
11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.11573909 |
12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.06962716 |
13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.02932362 |
14 | Adherens junction_Homo sapiens_hsa04520 | 1.99047166 |
15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.94186065 |
16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.86983088 |
17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82842943 |
18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68047182 |
19 | Phototransduction_Homo sapiens_hsa04744 | 1.61273544 |
20 | Platelet activation_Homo sapiens_hsa04611 | 1.58019063 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56982172 |
22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55365253 |
23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.55145991 |
24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54603618 |
25 | Focal adhesion_Homo sapiens_hsa04510 | 1.51795054 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45441811 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.44598883 |
28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.44170328 |
29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42036147 |
30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41657033 |
31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40962648 |
32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36714942 |
33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.36239296 |
34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.34924617 |
35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.33975054 |
36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.33068019 |
37 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.31726315 |
38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27752041 |
39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27594466 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.26968415 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25155182 |
42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24815801 |
43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23957457 |
44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.21376711 |
45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21104062 |
46 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.17962134 |
47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14909858 |
48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13037889 |
49 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10753059 |
50 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.09943196 |
51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.09315870 |
52 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.07268060 |
53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05733097 |
54 | Endocytosis_Homo sapiens_hsa04144 | 1.03971023 |
55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03116306 |
56 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01706189 |
57 | Malaria_Homo sapiens_hsa05144 | 1.00376615 |
58 | Renin secretion_Homo sapiens_hsa04924 | 0.99462121 |
59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99424873 |
60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97392075 |
61 | Axon guidance_Homo sapiens_hsa04360 | 0.97204791 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 0.94221337 |
63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94080635 |
64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93517970 |
65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91591560 |
66 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.91240557 |
67 | Morphine addiction_Homo sapiens_hsa05032 | 0.90584384 |
68 | Nicotine addiction_Homo sapiens_hsa05033 | 0.90502091 |
69 | Shigellosis_Homo sapiens_hsa05131 | 0.90411195 |
70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.89512728 |
71 | Measles_Homo sapiens_hsa05162 | 0.88044029 |
72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87189635 |
73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86974847 |
74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86183710 |
75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85772956 |
76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.85242308 |
77 | Tuberculosis_Homo sapiens_hsa05152 | 0.84712733 |
78 | Amoebiasis_Homo sapiens_hsa05146 | 0.84115339 |
79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83280309 |
80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82274607 |
81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80829889 |
82 | Prostate cancer_Homo sapiens_hsa05215 | 0.79683420 |
83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78970129 |
84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78832676 |
85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78543033 |
86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.76898852 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74819262 |
88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74056992 |
89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73364487 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72523132 |
91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71870597 |
92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71731858 |
93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71610936 |
94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71294900 |
95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70823893 |
96 | Influenza A_Homo sapiens_hsa05164 | 0.70323179 |
97 | Taste transduction_Homo sapiens_hsa04742 | 0.69862066 |
98 | ABC transporters_Homo sapiens_hsa02010 | 0.69476994 |
99 | Tight junction_Homo sapiens_hsa04530 | 0.68173083 |
100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67821837 |
101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67646710 |
102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67645659 |
103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67495632 |
104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66538071 |
105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65519726 |
106 | Hepatitis B_Homo sapiens_hsa05161 | 0.64476026 |
107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62474792 |
108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61428731 |
109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61364248 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.61232462 |
111 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.61223003 |
112 | Apoptosis_Homo sapiens_hsa04210 | 0.61197318 |
113 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60964133 |
114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60946470 |
115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60849170 |
116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59839416 |
117 | Hepatitis C_Homo sapiens_hsa05160 | 0.59588333 |
118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59341024 |
119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58395653 |
120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58349674 |
121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57845355 |
122 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57638505 |
123 | Insulin secretion_Homo sapiens_hsa04911 | 0.57108889 |
124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56663890 |
125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56537172 |
126 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56031011 |
127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55498161 |
128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55239885 |
129 | Phagosome_Homo sapiens_hsa04145 | 0.55184540 |
130 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53494680 |
131 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53020964 |
132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51144875 |
133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49101115 |
134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48338753 |
135 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47977595 |
136 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47745183 |
137 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46736954 |
138 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45851842 |
139 | Mineral absorption_Homo sapiens_hsa04978 | 0.45454318 |
140 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44116694 |
141 | Homologous recombination_Homo sapiens_hsa03440 | 0.43354164 |
142 | GABAergic synapse_Homo sapiens_hsa04727 | 0.41004551 |
143 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39315872 |
144 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38215639 |
145 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.36368643 |
146 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.35956739 |
147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32767756 |
148 | Long-term depression_Homo sapiens_hsa04730 | 0.30617486 |
149 | Peroxisome_Homo sapiens_hsa04146 | 0.30382900 |
150 | Salivary secretion_Homo sapiens_hsa04970 | 0.30166351 |
151 | Legionellosis_Homo sapiens_hsa05134 | 0.30106394 |
152 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29660553 |
153 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.26989537 |